ProductLife Group Announces Comprehensive Solution for Pharmaceutical and Biotechnological Product Development at DIA Conference

ProductLife Group Announces Comprehensive Solution for Pharmaceutical and Biotechnological Product Development at DIA Conference

Date: June 12, 2024

Location: San Diego, CA

ProductLife Group (PLG), a leading provider of product development and compliance services in the pharmaceutical and biotechnological sectors, is excited to announce a comprehensive solution aimed at transforming the landscape of drug development, underscoring PLG's commitment to advancing healthcare through innovation and expertise.

The newly unveiled Product Development Consulting capability within PLG represents a paradigm shift in how pharmaceutical and biotech companies approach the journey from concept to commercialization. By integrating the specialized capabilities of DSI, Cilatus, and Zwiers, along with PLG's global reach, this group offers unmatched, agile support across all stages of product development.

“Our mission is to simplify the complex process of bringing new drugs to market,” said Joanne Sullivan, EVP Americas & APAC at PLG. “By offering an end-to-end solution covering regulatory affairs, quality assurance, and comprehensive CMC services for both small and large molecules, we are setting a new standard to streamline the journey from concept to commercialization.”

The PLG Product Development Consulting team’s core competencies include deep regulatory expertise with a proven track record of navigating global regulatory landscapes, advanced quality assurance protocols to uphold stringent standards, and cutting-edge CMC services. This holistic approach ensures precision, compliance, and speed at every step, from initial discovery through to global market launch.

“In today's fast-paced and ever-evolving healthcare environment, our clients need a partner who can not only understand the intricacies of drug development but also anticipate and navigate the challenges that come with it,” Xavier Duburcq, CEO & Chairman of PLG, added. “PLG is that partner. Our global presence combined with localized expertise ensures our clients have the support they need, wherever they need it.”

This announcement at the DIA conference highlights PLG's dedication to fostering innovation and collaboration within the product development process. By leveraging state-of-the-art technologies, advanced analytics, and a client-centric approach, PLG's Product Development Consulting team is poised to drive the development and commercial success of transformative healthcare solutions.

PLG invites DIA conference attendees and the wider pharmaceutical and biotechnological community to learn more about this comprehensive solution and how it can accelerate their product development initiatives.

About PLG

ProductLife Group’s mission is to improve human health by delivering regulatory & compliance services for the safe and effective use of medical solutions. PLG supports clients through the entire product life cycle, combining local expertise with global reach spanning more than 150 countries. It provides consulting and outsourcing services in the areas of drug development, regulatory affairs, quality management and compliance, vigilance and medical information, covering both established products and innovative therapeutics & diagnostics.

With a goal of continuously improving the value delivered to people and customers, PLG is committed to long-term partnership, innovation, flexibility, and cost efficiency.

For more information, visit https://productlifegroup.com/

Meranda Parascandola
Meranda Parascandola
Meranda Parascandola is a member of the DSInpharmatics team and has written a variety of blog posts which you can read here.